Updates in Neurogenic Orthostatic Hypotension

Slides:



Advertisements
Similar presentations
This program will include a discussion of off-label treatment and investigational agents not approved by the FDA for use in the US, and data that were.
Advertisements

Assessing COPD in Primary Care
Systemic Lupus Erythematosus
Clinical Trials in IBD.
New Psoriasis Treatments
Psoriatic Arthritis.
Primary Care Challenges in Depression - To Treat or Refer?
Why Gene Therapy for Hemophilia?
This program will include a discussion of off-label treatment and investigational agents not approved by the FDA for use in the United States.
Management of Mild to Moderate Asthma
T-Cell Exhaustion: Can We Overcome It in Cancer?
Advances in Managing Inhibitors in Patients With Hemophilia A
5 Things NPs and PAs Need to Know About Tardive Dyskinesia
Progression After Cancer Immunotherapy in Advanced NSCLC
Motor Fluctuations in Parkinson Disease: Options and Strategies
Parkinson Disease:.
Chronic Rhinosinusitis
Ask the Onychomycosis Expert, Part 2
Ask the Onychomycosis Expert, Part 1
Standards of Care in Duchenne Muscular Dystrophy: A 2018 Update
Seasonal Allergic Rhinitis
New Insights Into Neurogenic Orthostatic Hypotension
Neurogenic Orthostatic Hypotension: Expert Perspectives on Diagnosis and Treatment Strategies.
Updates in Management of Atopic Dermatitis From Real Patient Cases
Advances in Dry Eye.
Induction Chemotherapy for Patients With High-Risk or Secondary AML
Successful Obesity Management and Counseling:
The Resurgence of Topical Treatments Across a Spectrum of Psoriasis
Chronic Idiopathic Urticaria
Addressing Disease Burden in Asthma
The Evolving Role of Immunotherapy in NSCLC
Optimizing Management of Advanced Bladder Cancer
A Frontline Clinician's Guide to Managing Opioid-Induced Constipation
Multidisciplinary Perspectives on Interstitial Lung Diseases
The Emerging Role of Immunotherapy in Hodgkin Lymphoma
Hyperhidrosis Is Burdensome!
Gene Therapy: Past, Present, and Future
Tackling Atopic Dermatitis
Therapeutic Approaches to the Management of EDS in OSA
Ask the Experts.
Immunotherapy for cSCC
Perspectives on the Impact of Inflammation in OA
Best Practices in the Clinical Management of Motor Symptoms Associated With Huntington Disease.
New Recommendations on How to Stage Hidradenitis Suppurativa
New Data on Emerging Treatments for Psoriasis
When Is Biologic Therapy Appropriate for HS?
Personalizing Management in the Care of Patients With Advanced Sarcoma
Parkinson Disease Psychosis
Talking With Your Patients About Excessive Sweating
When to Start and What to Use
Immune Checkpoint Inhibitors in Lung Cancer
Scientific Update.
Guide to Atopic Dermatitis
EGPA.
The Burden of Psoriasis:
Patient Questions and Expert Answers in Psoriasis:
This program will include a discussion of off-label treatment and investigational agents not approved by the Food and Drug Administration for use in the.
Novel Concepts in the Management of RCC
This program will include a discussion of off-label treatment and investigational agents not approved by the FDA for use in the United States, and data.
From Adjuvant to Metastatic in Melanoma
The Nurse View: Spotlight on Immune Checkpoint Inhibitors in Advanced Lung Cancer.
Getting PPG Under Control
Optimizing Outcomes in mRCC: Finding the Balance of Immune Inhibition
This program will include a discussion of off-label treatment or use of investigational agents not approved by the FDA for use in the US, and data that.
Checkpoint Inhibitors in First-Line Advanced NSCLC
Rational Pharmacotherapy Selection for Insomnia
This program will include a discussion of off-label treatment and investigational agents not approved by the FDA for use in the US, and data that were.
Merging the Art and Science of Managing nOH in Clinical Practice
Immune Checkpoint Inhibitors in Lung Cancer
Motor Fluctuations in PD
Presentation transcript:

Updates in Neurogenic Orthostatic Hypotension

This program will include a discussion of off-label treatments not approved by the FDA for use in the United States.

Introduction to nOH

Symptoms of nOH

nOH in Patients With PD

Questions to Ask the Patient During Screening

Identifying Symptoms of nOH

Confirming the Diagnosis A Stepwise Approach

Grading nOH Severity After Diagnosis Proposed Scale

Treatment of nOH

Medication Review What to Avoid

Nonpharmacologic Therapy

Pharmacotherapy of nOH

Pharmacotherapy of nOH Fludrocortisone*

Pharmacotherapy of nOH Vasoconstrictors

Droxidopa in nOH Reduction in Falls

Pharmacotherapy of nOH Pyridostigmine*

Managing Pharmacotherapy and Symptoms

Concluding Remarks

Abbreviations